MedPath

Primaquine Phosphate

PRIMAQUINE PHOSPHATE TABLETS, USP

Approved
Approval ID

0c8c2bc6-428b-40b6-8114-6df80290878d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Bayshore Pharmaceuticals, LLC

DUNS: 968737416

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Primaquine Phosphate

PRODUCT DETAILS

NDC Product Code76385-102
Application NumberANDA204476
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 17, 2020
Generic NamePrimaquine Phosphate

INGREDIENTS (11)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
Primaquine PhosphateActive
Quantity: 15 mg in 1 1
Code: H0982HF78B
Classification: ACTIM
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath